Viewing Study NCT01127750


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2025-12-28 @ 1:32 PM
Study NCT ID: NCT01127750
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2010-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module